Beta-2 Agonists Tied to ASD Risk? - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Beta-2 Agonists Tied to ASD Risk?

Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.

  • By

  • Andrea Surnit

  • June 24, 2026

  • 4 min

Share

Clinical Scorecard: Beta-2 Agonists Tied to ASD Risk?

At a Glance

CategoryDetail
ConditionAutism Spectrum Disorder
Key MechanismsPrenatal exposure to beta-2-adrenergic agonists
Target PopulationPregnant individuals with asthma
Care SettingObservational studies in high-income countries

Key Highlights

  • Prenatal exposure to beta-2-adrenergic agonists associated with ASD risk.
  • Adjusted pooled effect estimate of 1.29 for ASD with prenatal exposure.
  • Preconception exposure associated with an adjusted pooled effect estimate of 1.34.
  • Mixed evidence for associations with other neurodevelopmental outcomes.
  • Concerns about confounding by indication or asthma severity.

Guideline-Based Recommendations

Diagnosis

  • Consider prenatal exposure to beta-2-adrenergic agonists in ASD assessments.

Management

  • Continue asthma medication during pregnancy as per Global Initiative for Asthma guidance.

Monitoring & Follow-up

  • Monitor for neurodevelopmental outcomes in offspring of mothers exposed to beta-2-adrenergic agonists.

Risks

  • Potential confounding factors include maternal asthma severity and treatment indication.

Patient & Prescribing Data

Pregnant individuals with asthma requiring beta-2-adrenergic agonists.

Evidence suggests caution in interpreting associations with ASD due to confounding factors.

Clinical Best Practices

  • Assess maternal asthma management during pregnancy.
  • Evaluate the necessity of beta-2-adrenergic agonists on a case-by-case basis.

Related Resources & Content

Original Source(s)

Beta-2 Agonists Tied to ASD Risk?

  • by Andrea Surnit

  • June 24, 2026

Related Content

Phthalates Linked to Shorter Gestation

Researchers linked several pregnancy urinary biomarkers—especially plasticizer and combustion-related chemical metabolites—to small shifts in gestational age and fetal growth measures in the ECHO Cohort.

10 Growing US Metro Areas to Consider for Private Practice

These 10 metropolitan areas recorded population growth and had recently completed, ongoing, or announced health care infrastructure projects.

CHEST Issues OSA Guidance for Pregnancy

Guideline recommends screening, diagnosis, positive airway pressure therapy, and postpartum reassessment while highlighting the very low certainty of available evidence.